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Collagenated heretologous cortico-cancelleus 
bone mix (CHCCBM) is a bovine bone derived 
employed in maxillary and oral surgery. Some 
reports have demonstrated its clinical efficacy to 
restore alveolar ridge in pre-prosthetic surgery (1-3).
To investigate the molecular mechanism by 
which CHCCBM promotes osteoblast differentiation 
and proliferation, the quantitative expression of the 
mRNA of specific bone related genes, was examined 
in derived dental pulp stem cells treated CHCCBM. 
Dental pulp stem cells (DPSCs) represents an ideal 
source of stem cells because approachable niches 
containing a high number of stem cells compared 
to equal volumes of bone marrow (4-6). In this 
study the expression levels of specific genes were 
examined by means of real time RT-PCR in DPSCs 
after treatment with CHCCBM.
Gene expression in DPSCs was then compared 
with the gene expression in treated Human 
Osteoblasts (HOb) to evaluate the potential effect of 
this material in osteoblasts differentiation.
MATERIALS AND METHODS
Stem cells isolation from dental pulp, flow cytometric 
analyses and primary human osteoblasts cell culture were 
performed as previously described (4-6).
Cell treatment 
DPSCs and HOb were seeded with CHCCBM 
(Gen-Os, Tecnoss srl, Giaveno, Torino, Italy) at the 
concentration of 10 mg/ml. Another set of wells 
containing untreated cells were used as control. The cells 
were maintained in a humidified atmosphere of 5% CO2 
at 37°C. Cells were harvested at two time points, 15 and 
30 days, for RNA extraction. RNA processing, RT-PCR 
and statistical analyses were conducted as previously 
described (4-6). 
Collagenated heretologous cortico-cancelleus bone mix (CHCCBM) is largely employed in maxillary 
and dental surgery for regeneration procedures, and  is similar to human bone from chemical and 
physical point of view and promotes osteogenesis. In order to get more inside how this biomaterial 
induces osteoblast gene expression to promote bone formation, the mRNA levels of bone related genes 
were compared in human osteoblasts and dental pulp stem cells, using real time RT-PCR. The obtained 
results demonstrated that CHCCBM enhance stem cells differentiation and deposition of matrix by the 
activation of osteoblast related genes SP7, FOSL1 and SPP1.
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of promotes osteogenesis. It is of paramount 
importance since several situation determine bone 
loss. Among them are socket preservation after tooth 
extraction, peri-implants bone maintenance (7-16), 
ridge reconstruction in syndromic patients (17-23) 
and oral rehabilitation after oncological treatments 
(24-35)
 In order to get more inside how CHCCBM acts 
on DPSCs, changes in expression of bone related 
marker genes (RUNX2, SPP1, SP7, COLIA1, 
COL3A1, ALPL and FOSL1) and mesenchymal 
stem cells marker (ENG) were investigated by real-
time RT–PCR. DPSCs were isolated by enzymatic 
digestion and phenotipically characterized by flow 
cytometric analyses. Dental pulp derived cell were 
homogenously CD105+, CD90+, CD34-, CD45-, 
CD14-, which is a typical mesenchymal stem cells 
surface antigen profile. 
 The osteoinductive properties of CHCCBM were 
demonstrated by the up-regulation of SP7 during all 
the entire treatment both in treated DPSCs than in 
treated HOb. SP7 is a transcriptional factor involved 
in bone formation and osteoblast differentiation 
downstream of RUNX2 pathway. CHCCBM also 
modulate the expression of collagenic extracellular 
matrix genes, collagen type 1α1 (COL1A1) and 
collagen type 3α1 (COL3A1). 
 After 14 days, in treated DPSCs was observed the 
RESULTS
 Cell cultures were phenotipically characterized 
by flow cytometric analyses as previously reported 
(4-6). To study if CHCCBM stimulates osteoblasts 
differentiation and proliferation in DPSCs, several 
osteoblast genes and mesenchymal stem cells 
marker, were analyzed by quantitative real-time PCR 
after 14 days of treatment with CHCCBM. Treated 
DPSCs resulted in up-regulation of SP7, FOSL1 and 
SPP1 genes and down-regulation of ENG, RUNX2, 
COL3A1, COL1A1 and ALPL during the first 14 
days of treatment.
 Analyzing the results obtained in HOb, we 
observed that after 14 days of treatment SP7, ENG, 
FOSL1, COL1A1, COL3A1 and SPP1 were up-
regulated. The expression of RUNX2 and ALPL was 
down-regulated. “Two tailed ANOVA” comparison 
between DPSCs and HOb after the treatment showed 
that all genes were significantly differentially 
expressed after 14 days of treatment. (Table I). 
DISCUSSION
 CHCCBM (Gen-Os, Tecnoss srl, Giaveno, 
Torino, Italy) is widely used in several bone 
regeneration procedures in oral surgery due to its 
characteristics of resorption rate and capability 
Genes  DPSCs  HOb  Differentially expressed genes  
 Log10 RQ  Log10 RQ  p<0,005  
SP7  1,22  0,52  0,001  
ENG  -0,42  0,03  0,009  
FOSL1  0,25  0,26  0,001  
RUNX2  -0,42  -0,03  0,002  
COL3A1  -1,46  0,02  0,001  
COL1A1  -0,71  0,13  0,001  
ALPL  -0,54  -0,23  0,001  
SPP1  0,93  1,64  0,001  
 
Table I. Differentially expressed genes between DPSCs and HOb after 14 days of treatment.
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down-regulation of COL1A1 and COL3A1. Instead, 
in HOb, the two collagens type were up-regulated. 
Osteopontine (SPP1) was up-regulated during all 
the treatment both in DPSCs than in HOb. The up-
regulation of this gene suggests the differentiation 
effect of treatment. 
 ENG, also named CD105, a surface marker used 
to define a bone marrow stromal cell population 
capable of multilineage differentiation was down-
regulated in DPSCs and up-regulated in HOb 
during the entire treatment.  Another gene involved 
in osteoblast differentiation and modulated by 
CHCCBM was FOSL1. Both in DPSCs than in HOb 
this gene was up-regulated. FOSL1 is a component 
of the dimeric transcription factor AP-1 involved in 
the transcription of bone related genes. This study 
demonstrates that CHCCBM is capable of supporting 
osteoblast differentiation and extracellular matrix 
deposition and mineralization in mesenchymal stem 
cells by the activation of osteoblast related genes 
SP7, SPP1 and FOSL1. 
 Within the limits of this in vitro study related 
to the period of observation (2 weeks), it possible 
to infer that CHCCBM is a bone substitute that 
positively active gene related to bone formation.  
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Dental implant rehabilitation is a safe and well-
documented procedure. Dental implants have been 
shown to provide a reliable basis for fixed and 
removable prostheses (1).  Several techniques have 
been proposed for use of dental implants in retention 
and stabilization of denture in mandible.  Also in 
case of extremely resorbed mandible implants can 
be inserted with two procedures (2): use of (short) 
endosseous implants or augmentation of the mandible 
by means of grafting procedures, followed by the 
insertion of endosseous implants with either a fixed 
or removable prosthesis.
Knowing the ideal conditions for peri implant 
bone regeneration  has led to more refined concepts 
of implant loading in that secure primary stability 
and solid bone quality are considered to form a 
sound basis for early or immediate loading protocols 
(3). This recruitment is based on a cascade of events 
that starts with adsorption of biologically active 
molecules such as fibrin and thrombin as well as the 
attachment of platelets to the implant surface (4). 
Surface modifications of implants which enhance 
these initial steps could improve the recruitment of 
bone cells and shorten the critical period of peri-
implant bone formation, thereby decreasing the risk 
of implant loosening during early loading.
Today, important improvements have been 
made in understanding the prosthodontic aspects of 
implant-related treatment (5). Now it is possible to 
provide retention for fixed and removable prostheses. 
The rehabilitation of the edentulous mandible is a relatively common clinical problem and dentatl 
implants are popular medical device routinely use in daily practice. Recently a new type of two-piece 
spiral implants has been introduced in the market. Here a retrospective study is reported. A total of 
54 two-piece implants were inserted in mandible in the period between June and December 2017, 30 
in female and 24 in males. The median age was 53 ± 8. Implants replaced 11 incisors, 6 cuspids, 23 
premolars and 14 molars. Implant’ length was 10 mm, 11,50 mm and 13 mm in 16, 19 and 19 cases, 
respectively. Implant’ diameter was 3.3 mm, 3.75 mm and 4.2 mm in 22, 13, 19 cases, respectively. 
Twenty two fixtures were placed in totally edentulous patient and 32 in partially edentulous subjects. 
There were 4 single crowns, 28 implants bearing two or greater bridges, 4 removable dentures and 18 
supporting Toronto bridge. The overall mean follow-up was 13 ± 2 months. One implant was lost so that 
survival rate (SVR) was 98.15%. Then peri-implant bone resorption (success rate, SCR) was used to 
investigate peri-implant bone stability. No implant have a crestal bone resorption greater than 1.5 mm 
so that the implants studied are reliable devices for oral rehabilitation with a very high SCR and SVR.
Key words: two-pieces, implant, fixture, bone, loading
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orthopantomographs. Peri-implant crestal bone levels 
were evaluated by the calibrated examination of intra-oral 
radiographs and orthopantomograph x-rays after surgery and 
at the end of the follow-up period. The measurements were 
carried out medially and distally to each implant, calculating 
the distance between the implant’s neck and the most coronal 
point of contact between the bone and the implant. The bone 
level recorded just after the surgical insertion of the implant 
was the reference point for the following measurements. 
The measurement was rounded off to the nearest 0.1 mm. 
The radiographs were performed with a computer system 
By knowing dimensions of the implant, it was possible to 
establish the distance from the medial and distal edges of 
the implant platform to the point of bone-implant contact 
(expressed in tenths of a millimeter) by doing a proportion.
The difference between the implant-abutment junction 
and the bone level was defined as the Implant Abutment 
Junction (IAJ) and calculated at the time of operation and 
at the end of the follow-up.
Surgical protocol
All patients underwent the same surgical protocol. 
An antimicrobial prophylaxis was administered with 1g 
Amoxycillin 500 mg twice daily 5 days starting 1 hour 
before surgery. Local anesthesia was induced by infiltration 
with articaine/epinephrine and post-surgical analgesic 
treatment was performed with 600 mg Ibuprofen twice 
daily for 3 days. Oral hygiene instructions were provided.
Two-piece implants (Tuff type, Noris Medical Ltd. 
Nesher, Israel) were inserted in the period between June 
and December 2017. The implant neck was positioned 
at the alveolar crest level. A second operation was then 
performed after four months to loading by means a 
provisional prosthesis. The final restoration was usually 
delivered within 8 weeks. All patients were included in a 
strict hygiene recall.
Data analysis
Pearson-chi square test was used to detect those 
variables statistically associated to SVR and SCR.
RESULTS
A total of 54 two-piece implants (Tuff type, Noris 
Medical Ltd. Nesher, Israel) were inserted in mandible in 
the period between June and December 2017, 30 in female 
This kind of treatment improves oral function and 
patient satisfaction.  However,  the  use of implants 
in the extremely resorbed mandible due to neoplasm 
(6-17), malformations (18-24) and periodontal 
diseases (25-34) are still subjects of discussion in the 
literature.
Since a new type of fixture (Tuff type, Noris 
Medical Ltd. Nesher, Israel) has been introduced 
recently in the market, we analyses a series of two-
pieces implants inserted in lower jaw in order to 
evaluate their survival (i.e. total number of fixtures 
still in place at the end of the follow-up) and success 
rate (i.e. peri-implant bone resorption).
MATERIALS AND METHODS
Study design/sample
To address the research purpose, the investigators 
designed a retrospective cohort study. Subjects were 
screened according to the following inclusion criteria: 
controlled oral hygiene and absence of any lesions in the oral 
cavity; in addition, the patients had to agree to participate in 
a post-operative check-up program. The exclusion criteria 
were as follows: bruxists, consumption of alcohol higher 
than 2 glasses of wine per day, localized radiation therapy 
of the oral cavity, antitumor chemotherapy, liver, blood 
and kidney diseases, immunosupressed patients, patients 
taking corticosteroids, pregnant women, inflammatory 
and autoimmune diseases of the oral cavity.
Variables
Several variables are investigated: demographic (age and 
gender), anatomic (tooth site, jaws), implant (length, diameter) 
and prosthetic (i.e. single crowns, bridges, removable dentures 
and Toronto bridge.) variables.
The predictors of outcome are the percentage of implants 
still in place at the end of the follow-up period (i.e. survival 
rate – SVR) and the peri-implant bone resorption. The latter 
is defined as implant success rate (SCR) and it is evaluated 
according to the absence of persisting peri-implant bone 
resorption greater than 1.5 mm during the first year of loading 
and 0.2 mm/years during the following years.
Data collection methods
Before surgery, radiographic examinations were 
done with the use of intra-oral radiographs and 
(S1) 9Journal of Biological Regulators & Homeostatic Agents
of the positioning of the implants. Wittwer et al. 
(39) after an evaluation of immediate loading using 
computer-guided flapless surgery, concluded that 
trans-mucosal computer- assisted placement and 
immediate loading of mandibular implants is a high-
end approach to edentulism that provides excellent 
results while being minimally invasive. The goal of 
this advancement is not only to improve the precision 
and predictability of implant placement but also to 
change an invasive protocol for a flapless surgical 
procedure (non-invasive) and an immediate loading. 
Margonar et  al. (40) consider this technique a better 
planning of the implants, that makes the procedures 
more accurate, reduces surgical time, and leaves the 
patient more satisfied. 
In the present report only one implant was lost with 
a survival rate o f  98.15%. Then peri-implant bone 
resorption (i.e. delta  IAJ) was used to investigate 
SCR but no variable statistically affected implant 
outcome. In conclusion the studied implants (Tuff 
type, Noris Medical Ltd. Nesher, Israel) are reliable 
devices for oral rehabilitation with a very high SCR 
and SVR.
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Dental implants are used to restore missing tooth 
(1). When dental implants must be placed in the 
maxillary or mandible to replace lost teeth, first 
decisions that must be taken are about the size 
of the implants to choose and the protocols of 
implantation adopted to ensure the primary stability. 
According to the position where the implants are 
placed, they have a specific design. The main design 
parameters are diameter, length, shape and surface. 
Currently, the implants can vary in diameter from 
narrow, regular to wide (2). Also, the length of the 
implants is categorized as short, medium and long 
(2). Implants have reached the most frequent use in 
case of missing teeth as a single-tooth replacement, 
an implant is freestanding, not attached to adjacent 
teeth, and therefore, much easier to be cleaned. For 
patients who have lost multiple teeth, implants can 
provide support for a stable, healthy, and esthetic 
dentition that is not removable. Perhaps the most 
important aspect of implants is that they can restore 
quality of life (3).
The choice for a specific design always intends to 
reach the primary stability of the implant. The lack 
of primary stability can induce the formation of a 
soft tissue in the vicinity of implant. The implant 
mobility after surgery is the evident signal of 
failure caused by the formation of the fibrous tissue 
instead of the required osseointegration process. The 
stability depends on bone quality and implant design. 
The thickness of the cortical bone has a stronger 
influence for the primary stability and the length 
of the implants has weaker influence: the reason is 
that the cortical bone can provide a better stability 
instead the cancellous bone (4).
Wide diameter seems to present a great stability 
because it is evolved by cortical bone in a greater 
Oral rehabilitation by means dental implants has high standards of success.  Recently, a new type of 
two-pieces spiral implants has been introduced in the market. Since few reports focus of the efficacy of 
this medical device as a reliable tool for oral rehabilitation, here a retrospective study is reported. In the 
period June-December 2017 one hundred and two spiral fixtures were inserted, half in females and 51 in 
males. The median age was 56 ± 8 (min-max 36-73 years). Forty-eight implants were inserted in upper 
jawbone and 54 in mandible. Two implants were lost and thus survival rate (SVR) is 99.9%. Then 
peri-implant bone resorption was used to investigate the clinical success (success rate, SCR) over time. 
No implants have a crestal bone resorption greater than 1.5 mm in the first year follow up. No studied 
variable has an effect on clinical outcome. In conclusion the studied implants have high SCR and SVR 
so that they are good tools for oral rehabilitation.
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first year of loading and 0.2 mm/years during the 
following years.
Data collection methods
 Before surgery, radiographic examinations were 
done with the use of intra-oral radiographs and 
orthopantomographs. Peri-implant crestal bone 
levels were evaluated by the calibrated examination 
of intra-oral radiographs and orthopantomograph 
X-rays after surgery and at the end of the follow-up 
period. The measurements were carried out medially 
and distally to each implant, calculating the distance 
between the implant’ neck and the most coronal 
point of contact between bone and implant. The bone 
level recorded just after the surgical insertion of the 
implant was the reference point for the following 
measurements. The measurement was rounded off to 
the nearest 0.1 mm. The radiographs were performed 
with a computer system By knowing dimensions of 
the implant, it was possible to establish the distance 
from the medial and distal edges of the implant 
platform to the point of bone-implant contact 
(expressed in tenths of a millimetre) by doing a 
proportion.
 The difference between the implant-abutment 
junction and the bone crestal level was defined as the 
Implant Abutment Junction (IAJ) and calculated at 
the time of operation and at the end of the follow-
up. The delta IAJ is the difference between the IAJ 
at the last check-up and the IAJ recorded just after 
the operation. Delta IAJ medians were stratified 
according to the variables of interest.
Surgical protocol
 All patients underwent the same surgical protocol. 
An antimicrobial prophylaxis was administered with 
1g Amoxycillin 500 mg twice daily for 5 days starting 
1 hour before surgery. Local anesthesia was induced 
by infiltration with articaine/epinephrine and post-
surgical analgesic treatment was performed with 600 
mg Ibuprofen twice daily for 3 days. Oral hygiene 
instructions were provided.
 Two-piece implants were inserted (Tuff type, 
Noris Medical Ltd. Nesher, Israel) with a flap 
elevation approach. The implant neck was positioned 
at the alveolar crest level. A second operation was 
area of contact. In addition, a value torque of 45 Ncm 
is usually required during wide implants placements. 
However, disadvantages are pointed due to the heating 
generated during the drilling of the bone for wide 
implants that can cause possible injury to the tissue. 
Especially for cortical bones the heating is higher 
(5). Instead, the narrower implants are indicated for 
residual ridge too narrow for regular implants and 
also for reduced width interdentally space. However, 
the use of implants in the extremely resorbed crestal 
bone due to neoplasm (6-17), malformations (18-24) 
and periodontal diseases (25-34) are still subjects of 
discussion.
 Since a new type of fixture (Tuff type, Noris 
Medical Ltd. Nesher, Israel) has been introduced 
recently in the global market, we analyses a series 
of two-pieces implants inserted in different sites 
of lower and upper jaw in order to evaluate their 
survival (i.e. total number of fixtures still in place at 
the end of the follow-up) and success rate (i.e. peri-
implant bone resorption).
MATERIALS AND METHODS
Study design/sample
 To address the research purpose, the investigators 
designed a retrospective cohort study. Subjects 
were screened according to the following inclusion 
criteria: controlled oral hygiene and absence of any 
lesions in the oral cavity; in addition, the patients had 
to agree to participate in a post-operative check-up 
program.
Variables
 Several variables are investigated: demographic 
(age and gender), anatomic (upper or lower jaws, 
tooth site), implant (length, diameter) and prosthetic 
(Toronto bridge, crown or ball attachment to fix 
removable prosthesis) variables.
 The predictors of outcome are the percentage 
of implants still in place at the end of the follow-
up period (i.e. survival rate – SVR) and the peri-
implant bone resorption. The latter is defined as 
implant success rate (SCR) and it is evaluated 
according to the absence of persisting peri-implant 
bone resorption greater than 1.5 mm during the 
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parameter is crucial for the stabilization in the cortical 
bone. However, the surface rough implants also tend 
to present a strong behaviour to culminate in the 
osseointegration compared to the smooth ones (3).
 Among various factors in predicting the success 
of implant therapy, factors determined by the patient 
are the volume and density of available bone (3,4). 
The use of multiple implants in patients that needs 
total oral rehabilitation can manage different kind 
of bone and this fact needs to use different surgical 
procedures for proper management of bone. It 
becomes so mandatory a straight treatment planning 
and must be closely discussed with prosthodontic 
colleagues and patients. Several surgical techniques 
can be used for suitable choices of treatment 
considering bone block grafting, ridge splitting, 
sinus lifting, immediate implant placement, socket 
preservation, guided bone regeneration, short 
implant, temporary mini implant, titanium mesh 
tray, etc. Occasionally, major surgeries including 
microvascular surgery and orthognathic surgery 
may be needed for reconstruction and discrepant 
correction of the jaws prior implant placement (6-
17). 
 Bone quantity and quality are determined by 
the localization and type of bone according to the 
criteria established by Lekholm and Zarb (35). The 
authors found significant differences in stability as a 
function of localization, with lower ISQ values for 
the maxillary versus mandibular sites, which were 
explained by the greater stability of implants in 
dense cortical bone than in trabecular bone.
 In the present report only one implant (Tuff type, 
Noris Medical Ltd. Nesher, Israel) was lost with a 
survival rate o f  99.9%. Then peri-implant bone 
resorption was used to investigate SCR but no 
variable statistically affected implant outcome. 
 In conclusion the studied implants are reliable 
devices for oral rehabilitation with a very high SCR 
and SVR.
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then performed after four months to loading by 
means a provisional prosthesis. The final restoration 
was usually delivered within 8 weeks. All patients 
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Data analysis
 Pearson-chi square test was used to detect those 
variables statistically associated to SVR and SCR.
RESULTS
 In the period June-December 2017 102 two-
piece spiral implants (Tuff type, Noris Medical Ltd. 
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in males. The median age was 56 ± 8 (min-max 
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 Thirty-six fixtures were placed in totally 
edentulous patient and 66 in partially edentulous 
subjects. There were 16 single crowns, 50 implants 
bearing two or greater bridges, 4 removable dentures 
and 32 supporting Toronto bridge. The overall mean 
follow-up was 11 ± 1 months. One implant was lost, 
survival rate (SVR) = 99.9%. Then peri-implant 
bone resorption (success rate, SCR) was used to 
investigate peri-implant bone stability. No implant 
have a crestal bone resorption greater than 1.5 mm 
in the first year follow up. No studied variable has an 
effect on clinical outcome.
DISCUSSION
 Osseointegration is known as “a process whereby 
a clinically asymptomatic rigid fixation of alloplastic 
materials is achieved and maintained in bone during 
functional loading” (3).
 The implants design, or else, the length, diameter, 
shape and surface are important to obtain a primary 
stability and osseointegration in the early stages of 
implantation. Considering the diameter tends to have 
a strong influence on the primary stability, since this 
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other chemical methods of induction of osteogenesis. 
The stimulus to the formation of new bone can be 
induced through different techniques a) faradic 
systems in which electrodes are applied on the bone 
segment to be treated, b) electric fields directly on 
the bone of the capacitive systems, c) ultrasound 
applied to the bone, d) pulsed electromagnetic fields 
directly on the bone. 
 Since non-union can be happen also in dental 
and maxillofacial surgery after oncological resection 
(11-22), orthognatic surgery  (23-29) and in 
infected wound  we shortly reviewed main points of 
biophysical stimulation.
Mechanism of action 
 The different methods of biophysical stimulation 
of osteogenesis seem to have the as a target the 
cell membrane which absorb the stimuli and then 
redistribute them to the different cellular metabolic 
The bone behaves like a mechanical-electrical 
transducer so that the mechanical stimuli are 
transformed, by piezoelectric systems inside the 
bone, into electrical signals biologically active on 
bone formation (1-10). 
Learning about the electrical properties of bone 
and on the comprehension that in a fracture callus 
as in general in the presence of osteogenesis there is 
an electronegative potential, orthopedic surgeons use 
the electrical stimulation to promote osteogenesis to 
treat those pathologies in which it has stopped or 
delayed.
 The electrical stimulation of osteogenesis is a 
methodic in the field of the “clinical biophysic” 
which studies the employ in the clinical practice 
of physic energies applied to biological systems. 
Biophysical stimulation includes methods for 
applying an electromagnetic, electrical, mechanical-
ultrasonic force on a skeletal site and is distinct from 
Biophysical therapy can be performed using inductive, capacitive, mechanic or implanted devices. The 
mechanism of action of physical stimuli is at a membrane level where the activation of calcium channels 
determines the enhancement of cell proliferation and the production of growth factors. Biophysical 
therapy should be performed using devices and modalities described in the literature. The biophysical 
stimulation of osteogenesis is effective in the enhancement of the biology of fracture healing in presence 
of a correct orthopedic treatment in terms of good alignment and stabilization at the fracture site. The 
choice of which method must be used depends on the segment of bone that has to be treated, the type of 
fracture and if it is possible to apply the device on the skin. The presence of internal or external fixation 
devices is not a contraindication.
Key words: therapy, osteogenesis, electromagnetic, fields, ultrasound
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activation and calmodulin. PEMFs also modulate 
the expression of genes encoding for collagenous 
and noncollagenous extracellular matrix proteins 
(COLA2A Osteonectin) and cytoskeletal proteins 
(FN1 and VCL). PEMF reduce the expression of 
degradation processes of extracellular matrix both 
inducing the expression of TIMP1, an important 
metallo-peptidase inhibitor, and directly reducing 
metallo- peptidases expression (MMP-11). PEMFs 
seem to exert an anabolic effect on cells acting on 
it in different ways. PEMF are able to stimulate 
osteoblastic differentiation and proliferation. PEMF 
promote the production of extracellular matrix and 
mineralization while decreasing their degradation 
and absorption processes. 
Therapeutic indications 
 The first therapeutic indications of biophysical 
methodic were in the treatment of delayed union and 
non-union (1-10). Although all the four biophysical 
methods were shown to be effective in treatment 
of pseudo-arthroses and delayed union, the most 
effective are PEMF. In any case every biophysical 
method cannot be useful if the orthopedic treatment is 
non correct and if there is a gap between the fragment 
of the fracture greater than half of the diameter of the 
skeletal segment to be treated. In studies performed 
by using inductive methods, that are less invasive 
and easier to handle than faradic systems, the healing 
rate obtained was between the 77% and the 90% of 
the cases. With capacitive systems were obtained 
good healing rate results (the 70% of the cases) but 
less when compared to PEMF. Both inductive and 
capacitive systems are particularly indicated in the 
presence of infected lesions and the infection does 
not interfere on the success of the therapy. Moreover, 
the inductive system was demonstrated to be more 
effective than surgery in the presence of infection. 
The biophysical treatment would be preferred in the 
first instance in respect of other surgical methods, 
when a delayed union or a nonunion must be treated 
in the presence of a good mechanical stabilization of 
the fracture with good reduction of the fragments. 
 PEMF and ultrasounds are indicated in the 
treatment of recent fractures in which the fracture 
site, the eventual exposition, the feature of the 
pathways. Particularly, PEMF can modify  important 
physiological parameters of cells cultured in vitro like 
cell proliferation, signal transduction, transcription, 
synthesis and secretion of growth factors. PEMF 
can induce cell proliferation in mitogen stimulated 
lymphocytes and to improve IL-2 receptor 
expression and IL-2 utilization in lymphocytes 
from aged donors, which are characterized from 
defective production and utilization of this growth 
factor. PEMF exposure induces cell proliferation 
in human osteoblasts and chondrocytes cultured in 
vitro (1-10). Electromagnetic fields determine signal 
transduction by means of intracellular release of 
Ca2+ leading to an increase in cytosolic Ca2+ and 
an increase in activated cytoskeletal calmodulin. 
PEMF induce a dose-dependent increase in bone 
and cartilage differentiation and the up-regulation of 
mRNA expression of extracellular matrix molecules, 
proteoglycan, and type II collagen. The acceleration 
of chondrogenic differentiation is associated with 
increased expression of transforming growth factor 
b1 (TGFb1) mRNA and protein suggesting that the 
stimulation of TGFb1 may be a mechanism through 
which PEMF affect complex tissue behavior such as 
cell differentiation and through which the effects of 
PEMF may be amplified. PEMF are also postulated 
to act at a membrane level influencing signal 
transduction of several hormones or growth factors 
like PTH, IGFII and Adenosine A2a producing the 
amplification of their transmembrane receptors. 
PEMF exposure induces an upregulation of BMP-
2,-4,-7 mRNAs depending on the duration of the 
exposure with a peak after 24 h. Sollazzo et al. (5) 
described an overall analysis about the effects of 
PEMF on human osteoblast-like cells in vitro, using 
microarray technology, demonstrating that PEMF 
enhance osteogenesis through the up and down 
regulation of several genes that regulate osteoblast 
proliferation and differentiation. More specifically, 
PEMF determined the up regulation of Runx2, 
which is the transcription factor essential for bone 
formation, through the over expression of HOXA 
10. Moreover, PEMF determined the up regulation 
of AKT1 which maintain bone mass and turnover. 
PEMF exposure induces the overexpression of 
P2RX7, which determine the Ca2+ channels 
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in the conservative treatment of avascular necrosis 
of the femoral head (stages I and II of Ficat 
classification) significantly limiting the progression 
of the disease toward hip osteoarthritis thus reducing 
the need of total hip replacement. 
 To reach best results coming from the employ of 
the different biophysical methods, it is very important 
to strictly follow their clinical indications. Therefore, 
much attention must be paid to prescribe one method 
instead of another depending on the pathology to 
treat. In general, the methods in which short daily 
application times are needed require a prolonged 
treatment. For instance, in the case of delayed unions, 
the employ of ultrasound stimulation, that require 
20 minutes of daily application time, can last one 
or three months after the treatment with inductive 
method that instead require daily application times 
over 6 h. For the inductive method, if treatment is 
performed with a daily application OF less of 5 h, 
the success rate is worse than the treatment done 
with the correct daily application of more than 6 h 
(60% vs 90%). Since the capacitive and ultrasound 
techniques require the direct applications of the 
device on the skin, it’s not possible to use them 
whenever the patients wear a cast. 
 The use of inductive systems is difficult in the 
treatment of the shoulder, where instead the capacitive 
technique is particularly indicated in the presence 
of an internal fixation and is not a contraindication 
for the use of biophysical techniques. However, the 
presence of an internal fixation with a plate can act as 
a shielding for ultrasounds. In this case ultrasounds 
must be applied opposite to the plate. In the case 
of infection are recommended the inductive and 
capacitive methods while the use of faradic systems 
appears cannot be used. Osteogenesis stimulation 
may be considered a useful technique for periodontal 
disease and peri-implantitis treatment, and it has 
been increased a great interest in the last years both 
in basic (2-16) and advanced research (17-31).
DISCUSSION
 The improvement of osteogenesis is important 
because of the wide clinical applications it may 
have. This is possible by employing the biophysical 
fracture, and the conditions of the patient (metabolic 
diseases, systemic diseases, therapies, style of life, 
smoking) are suggestive for difficulties in fracture 
healing (“at risk fractures”). At risk fractures are the 
20% of all fractures and there are high probabilities 
of nonunion (25-50%). Therefore, the employ of 
biophysical stimulation appears indicated because 
of its particularly favorable cost/benefits ratio. 
Biophysical therapy can be employed  when callus 
formation is scarce or absent bone. In randomized 
double-blind studies demonstrated that the employ 
of biophysical stimulation makes it possible to 
shorten the time needed for bone consolidation of 
about 25-30% and that it is possible to accelerate 
healing process of fractures that normally need over 
4 months to heal. The Electrical stimulation also 
shortened the mean healing time in the presence 
of wide exposition of the fragments and extensive 
damage of soft tissues at the fracture site. The employ 
of a cast or of an external fixator didn’t interfere with 
PEMF action. The stimulation with capacitive fields 
was demonstrated to be effective for the treatment of 
stress fractures in the athletes with high healing rate 
(88%). 
 PEMF are also effective in the treatment of 
articular fractures were a damage of the cartilage 
is present. In these cases, PEMF allow to treat both 
cartilage and bone lesions. In fact, PEMF producing 
the amplification of transmembrane receptors of 
Adenosine A2a reduce the damage on the joint 
environment form inflammatory reaction limiting 
the catabolic effects of pro inflammatory cytokines 
on cartilage and producing an up regulation of 
proteoglycans synthesis. In experimental and clinical 
studies PEMF were demonstrated to favor the 
subchondral bone healing, to prevent subchondral 
sclerosis and degeneration of articular cartilage, thus 
limiting arthritis progression. 
 The tree methods of osteinduction described 
before are successfully employed to favour the fusion 
and integration of bone grafts in spinal fusions. In 
particular, the capacitive method was demonstrated 
to be effective in improving healing rate in patients 
undergone spinal fusion (65% placebo and 84% 
active device). 
 The inductive method is particularly effective 
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methods if the physician follows the correct 
indications, modality and application times. Much 
research is present in the current literature to 
comprehend the mechanism of action through which 
physical forces produce their biologic effect. PEMF 
and capacitive systems are known to act in different 
ways on cell and tissues. A more detailed knowledge 
of the mechanism of action of these methods 
permitted the extension of their clinical applications. 
PEMF are an important example of that. In fact, they 
were originally employed in the treatment of delayed 
union and non-union, but since their chondro-
protective properties were demonstrated, PEMF are 
successfully used also in the treatment of cartilage 
pathologies. 
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 The rehabilitation of the edentulous maxilla 
is a relatively common clinical problem. Missing 
dentition can be replaced by dentures (not appreciated 
by the patient because of their instability, discomfort 
and negative psychological impact), or implant-
supported prosthesis, which could be the ideal 
solutions, although the lack of sufficient bone volume 
is a common problem (1-2). So, although dental 
implants have been accepted as a viable treatment 
option for completely and partially edentulous 
patients, the bone heights between 10 and 12 mm 
are considered the minimal amount of bone required 
to place implants of sufficient length to guarantee a 
good prognosis.
 In the posterior maxilla, the proximity of the 
maxillary sinus and insufficient quality and quantity 
of alveolar bone to achieve implants favorable 
anchorage may create problems for implant 
rehabilitation and thus zygomatic implants have 
been recently proposed as a successful solution. 
 In conventional implantology, several solutions 
have been described to accomplish implant 
placement in these sites, such as sinus lift or the use 
of short/tilted implants. 
 Here we analyses a series of two-pieces spiral 
implants (Tuff type, Noris Medical Ltd. Nesher, 
Israel) in order to evaluate their survival (i.e. total 
number of fixtures still in place at the end of the 
follow-up) and success rate (i.e. peri-implant bone 
resorption).
MATERIALS AND METHODS
Study design/sample
 To address the research purpose, the investigators 
designed a retrospective cohort study. The study 
population was composed of patients admitted at the 
private practice for evaluation and implant treatment 
It is generally accepted that maxilla has a less bone quality than mandible and this fact makes 
implant rehabilitation more complex. Recently a new type of spiral implants has been introduced in the 
global market. Since few reports are available a retrospective study was performed. A total of 48 two-
piece spiral implants were inserted, 21in female and 27 in males. The median age was 58 ± 8. Implants 
replaced 10 incisors, 9 cuspids, 25 premolars and 4 molars. Implant’ length was 10 mm, 11.5 mm and 
13 mm in 13, 24, and 11 cases, respectively. Implant’ diameter was 3.3 mm, 3.75 mm and 4.2 mm in 25, 
17 and 6 cases, respectively. One implant was lost, survival rate (SVR) = 97.91%. Then peri-implant 
bone resorption was used to investigate success rate (SCR). The mean bone resorption was 0.3 mm after 
an average period of 1 year follow up. In conclusion the implants studied are reliable devices for oral 
rehabilitation with a very high SCR and SVR.
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performed with    a computer system as described 
elsewhere (1). 
The difference between the implant-abutment 
junction and the bone crestal level was defined as 
the  Implant Abutment Junction (IAJ) and 
calculated at the time of operation and at the end 
of the follow-up. The delta IAJ is the difference 
between the IAJ at the last check-up and the IAJ 
recorded just after the operation.
Surgical protocol
 All patients underwent the same surgical protocol. 
An antimicrobial prophylaxis was administered 
with 1g Amoxycillin 500 mg twice daily for 5 days 
starting 1 hour before surgery. Local anesthesia was 
induced by infiltration with articaine/epinephrine 
and post-surgical analgesic treatment was performed 
with 600 mg Ibuprofen twice daily for 3 days. Oral 
hygiene instructions were provided.
Two-piece implants were inserted (Tuff type, Noris 
Medical Ltd. Nesher, Israel). The implant neck 
was positioned at the alveolar crest level. A second 
operation was then performed after four months to 
loading by means a provisional prosthesis. The final 
restoration was usually delivered within 8 weeks. All 
patients were included in a strict hygiene recall.
Data analysis
 Pearson-chi square test was used to detect those 
variables statistically associated to SVR and SCR.
RESULTS
 A total of 48 two-piece spiral implants were 
inserted, 21in female and 27 in males. The median 
age was 58 ± 8. Implants replaced 10 incisors, 9 
cuspids, 25 premolars and 4 molars. Implant length 
was 10 mm, 11,5 mm and 13 mm in 13, 24, and 11 
cases, respectively. Implant diameter was 3.3 mm, 
3.75 mm and 4.2 mm in 25, 17, 6 cases, respectively. 
One implant was lost, survival rate (SVR) = 97.91%. 
Then peri-implant bone resorption was used to 
investigate success rate (SCR). The mean bone 
resorption was 0.3 mm after an average period of 
1-year follow-up.
Statistical analysis performed by detecting bone 
resorption around implants did not demonstrated 
between June and December 2017.
 Subjects were screened according to the 
following inclusion criteria: controlled oral hygiene 
and absence of any lesions in the oral cavity; in 
addition, the patients had to agree to participate in a 
post-operative check-up program.
 The exclusion criteria were as follows: bruxists, 
consumption of alcohol higher than 2 glasses of wine 
per day, localized radiation therapy of the oral cavity, 
antitumor chemotherapy, liver, blood and kidney 
diseases, immunosupressed patients, patients taking 
corticosteroids, pregnant women, inflammatory and 
autoimmune diseases of the oral cavity.
Variables
 Several variables are investigated: demographic 
(age and gender), anatomic (tooth site, jaws), implant 
(length and diameter), and prosthetic (Toronto 
bridge, crown or ball attachment to fix removable 
prosthesis) variables.
 The predictor of outcome is the percentage of 
implants still in place at the end of the follow-up 
period (i.e. survival rate - SVR) and the peri-implant 
bone resorption. The latter is defined as implant 
success rate (SCR) and it is evaluated according 
to the absence of persisting peri-implant bone 
resorption greater than 1.5 mm during the first year 
of loading and 0.2 mm/years during the following 
years.
Data collection methods
 Before surgery, radiographic examinations were 
done with the use of intra-oral radiographs and 
orthopantomographs. 
 Peri-implant  crestal  bone  levels  were 
evaluated   by   the calibrated examination of intra-
oral radiographs and orthopantomograph x-rays after 
surgery and at the end of the follow-up period. The 
measurements were carried out medially and distally 
to each implant, calculating the distance between 
the implants’ neck and the most coronal point of 
contact between the bone and the implant. The bone 
level recorded just after the surgical insertion of the 
implant was the reference point for the following 
measurements. The measurement was  rounded 
off to the nearest 0.1 mm. The radiographs were 
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 Titanium (Ti) is the most widely used material in 
implantology for dental, orthopedic and maxillofacial 
purposes due to their excellent biocompatibility and 
mechanical properties (1-21). In implantology a 
considerable number of implants failed due to the 
unsuccessful integration of the material with the 
surrounding tissue. The main causes of this bad 
outcome are  inflammation, loss of supporting bone 
and soft tissue recession (22-31).
 Cell colonization of biomaterials is characterized 
by the modification of cytoskeleton followed by 
activation of genes related to proliferation, migration 
and differentiation.
 The surface-design enhanced tissue attachment, 
fibroblast proliferation and the formation of 
connective tissue fibers perpendicular to the implant 
(24, 25), with the  formation of a biological seal that 
prevented bacterial colonization. 
 Different biocompatible materials are currently 
employed for implants. Among these, Ti is considered 
a “gold standard” because of its biocompatibility and 
good corrosion resistance (1,2).  Recently, a new type 
of implant (Noris Medical Ltd., Nesher, Israel) with a 
spiral form has been produced. The aim of this work 
is to verify the effect of titanium layer using Human 
Fibroblast (HFb) culture. The expression levels of 
some adhesion and traction-resistance related genes 
(COL11A1, COL2A1, COL9A1, DSP, ELN, HAS1, 
TFRC) were analyzed using Polymerase Chain 
Reaction.
MATERIALS AND METHODS
Titanium implants
 Four implants (Tuff type, Noris Medical Ltd. 
Nesher, Israel) were placed in wells. 
Titanium (Ti) is that the most generally used material for dental, orthopedic and maxillofacial 
purposes thanks to its excellent biocompatibility and mechanical properties. Several data suggest that 
prosthesis anchorage to bone and soft tissue are often modulated by surface characteristics. Fibroblasts 
are the soft tissues cells concerned in producing extracellular matrix and collagen and their tight 
connection to implant neck is of paramount importance in preventing peri-implant infection. The aim of 
this work is to grow Human Fibroblast (HFb) for seven days in wells containing (or not) dental implants. 
The expression levels of some adhesion and traction-resistance related genes (COL11A1, COL2A1, 
COL9A1, DSP, ELN, HAS1, and TFRC) were analyzed using Polymerase Chain Reaction. Our results 
demonstrated that several genes encoding for extracellular matrix proteins are activated so giving more 
insight to the comprehension of the mechanism of cell to surface adhesion.
Key words: titanium, implants, fibroblast, gene, expression
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expressed as fold changes relative to the expression 
of the untreated HFb. 
 Forward and reverse primers for the selected 
genes were designed using primer express software 
(Applied Biosystems, Foster City, CA, USA)   and 
are listed in Table I. 
Real Time PCR
 All PCR reactions were performed in a 20 
µl volume using the ABI PRISM 7500 (Applied 
Biosystems, Foster City, CA, USA). Each reaction 
contained 10 µl 2X Power SYBR® Green PCR 
Master Mix (Applied Biosystems, Foster City, 
CA, USA), 400 nM concentration of each primer, 
and cDNA. All experiments were performed 
including non-template controls to exclude reagents 
contamination. PCRs were performed with two 
biological replicates.
RESULTS
 Activation of extracellular matrix proteins were 
evaluated by measuring the gene expression levels 
after 7 days of treatment. Empty well was the control 
surface to compare the gene expression of implant 
surface. Fig. 1 showed the differentially expressed 
genes in the implants respect to the control surface.
DISCUSSION
 A close joint between implant and surrounding 
tissues is essential for the maintenance and success 
of a dental implant in longevity. This result depends 
on the growth and adhesion of the cells of the 
periodontium to the tissue-implant interface.
 The aim of this study was to compare fibroblasts 
behavior cultured in wells containing dental implants 
compared with empty wells.
After 7 days of treatment the expression levels of 
genes COL2A1, COL9A1, COL11A1, ELN, DSP 
and HAS1 were measured by relative quantification 
method using PCR. COL2A1, COL9A1 and 
COL11A1 are involved in conferring resistance to 
compressive forces (32). After 7 days of treatment 
we observed the up-regulation of all three collagens 
in fibroblast cultivated respect to control. 
Cells Culture
 For the investigation, HFb at the second passage 
were seeded on wells (with or without implants) The 
medium was changed three times a week and the 
cells were maintained in a humified atmosphere of 
5% CO2 at 37°C. Cells were trypsinized and lysed 
for RNA extraction, after 7 days of treatment.
RNA processing and Real Time PCR
 Reverse transcription to cDNA was performed 
directly from cultured cell lysate using the TaqMAn 
Gene Expression Cells-to-Ct Kit (Ambion Inc., 
Austin, TX, USA) following manufacturer’s 
instructions. Briefly, cultured cells were lysed with 
lysis buffer and RNA released in this solution. Cell 
lysate were reverse transcribed to cDNA using the 
RT Enzyme Mix and appropriate RT buffer (Ambion 
Inc., Austin, TX, USA).
 Finally, the cDNA was amplified by real-time 
PCR using Power SYBR® Green PCR Master Mix 
(Applied Biosystems, Foster City, CA, USA) and the 
specific assay designed for the investigated genes.
 Expression was quantified using real time PCR. 
The gene expression levels were normalized to the 
expression of the housekeeping gene TFRC and were 
 
Gene symbol Primer sequence (5’>3’) 
COL11A1 
Fw  AGATGAGGCAAACATCGTTGA 
Rev  ATCAGAATCCCTGCCGTCTA 
COL2A1 
Fw  GCGACGACATAATCTGTGA 
Rev  GTCCTTTGGGTCCTACAATA 
COL9A1 
Fw  GTAACAGTGAAGGGGTCGTGA 
Rev  TTGGCCAATCCTGATCTTTG 
DSP 
Fw  ATGACCTGAGGAGAGGACGAA 
RevAGGCTCTCTCTTTCCTGTACCAC 
ELN 
Fw  CTAAATACGGTGCTGCTGGC 
Rev  CATGGGATGGGGTTACAAAG 
HAS1 
Fw  CTCGGAGATTCGGTGGACTA 
Rev   CGCTGATGCAGGATACACAG 
TFRC 
Fw  CGCTGGTCAGTTCGTGATTA 
Rev   GCATTCCCGAAATCTGTTGT 
Table I. Primers sequences.
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surface (after 7 day of fibroblast culturing) promotes 
the production of protein involved in cell-cell 
and cell-matrix adhesion and in stress-resistance, 
required for a good outcome in dental implantology. 
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